The Journal of Headache and Pain

Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"

The Journal of Headache and Pain Cover Image
Open Access

Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties

  • Giuseppe Stirparo,
  • Fabio Palazzo,
  • Sergio De Filippis and
  • Paolo Martelletti
The Journal of Headache and PainOfficial Journal of the Italian Society for the Study of Headaches4:00019


Triptans are presently a milestone in the treatment of migraine patients. Because of their effectiveness and safety, they have radically improved migraine treatment but their use has meant a substantial increase in spending for medicines. We compared available pharmaceutical forms, pack sizes, indications and dosages of triptans as listed in the summary of product characteristics of eight countries. We found that several differences exist between countries in the presentations of the triptans and in their licensing.

Key words TriptansIndications



By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.